Official journal of @SaudiPhSociety published by @ElsevierConnect publishing clinically oriented submissions of pharmaceutical sciences | @_KSU l @PharmacyKSU
๐๐๐ฎ๐๐ข ๐๐ก๐๐ซ๐ฆ๐๐๐๐ฎ๐ญ๐ข๐๐๐ฅ ๐๐จ๐ฎ๐ซ๐ง๐๐ฅ (๐๐๐) is seeking reviewers!
fill the form to show your interest to join SPJ reviewer list
๐https://t.co/oOUq5JxkTW
Special thanks to our team including editorial board members and reviewers for their tremendous hard work, time, and effort towards the success and new records achievements during 2023.
During our annual meeting at the @SaudiPhSociety , we had a farewell for our Editor-in-Chief Prof. Aws Alshamsan and associate editors Dr. Hisham A. Badreldin, and Dr. Nabil A. Alhakamy. Many thanks for the incredible work and continuous efforts.
Special issue โจ
Towards Sustainable and Equitable Healthcare: Integrating Health Economics, and Policy.
Submission deadline: 1 August 2024 ๐
Read More | https://t.co/raCSF9Y1nm
Forensic Toxicology Scientific contribution in preventing drug- related fatalities in the Middle East and North African ( MENA ) region ๐.
https://t.co/raCSF9Y1nm
30 Years of glory!
We are happy to announce our two special issues celebrating the 30th anniversary in SPJ! ๐
๐ซ Special discount โ30%โ and more!
Check out below โฌ๏ธ
https://t.co/raCSF9Y1nm
The Editor-in-chief Prof. Aws Alshamsan and deputy editor-in-chief Dr. Sary Alsanea, extend their appreciation and gratitude to the former associate editor Dr. Ghazwa Korayem for her outstanding efforts during her journey with SPJ editorial board for the years 2022-2023.
We had our annual meeting at @SaudiPhSociety . We reviewed 2022 metrics and discussed 2023 improvement plan.
Many thanks to the editorial board, reviewers, authors, readers, the Saudi Pharmaceutical Society and all our success partners.
SPJ participated in the 2nd KSU, Journals Unit Symposium.
Of behalf of Prof. Aws Alshamsan our Eiditor-in-chief (EiC), Dr. Sary Alsanea was honored with EiCs of @_KSU journals.
Conclusion & final remarks :
SA needs to overcome the imports of the drug industry, by simplifying regulations, investing and encourage investors to the local industry and R&D, enhance patent protection, to improve the local pharma production.